RNAZ

TransCode Therapeutics, Inc. RNAZ

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode RNAZ RVPH ZVSA UNCY ENSC DRMA MTVA PALI
6M 25.11 % -3.68 % -79.22 % -18.98 % 10.84 % 413.61 % -32.57 % 186.94 %
YTD -79.54 % -67.67 % -85.32 % -43.94 % -72.73 % 198.56 % -53.66 % 7.53 %
1Y -96.86 % -47.16 % -93.10 % 14.73 % -11.76 % 221.71 % -61.35 % -41.35 %
3Y -100.00 % -83.29 % -100.00 % -20.00 % -99.70 % -97.44 % -61.35 % -97.39 %
5Y -100.00 % -93.97 % -100.00 % -91.12 % -99.99 % -99.67 % -61.35 % -99.93 %
10Y -100.00 % -93.31 % -100.00 % -91.12 % -99.99 % -99.67 % -61.35 % -100.00 %
From the beginning -100.00 % -93.31 % -100.00 % -91.12 % -99.99 % -99.67 % -61.35 % -100.00 %

Dividend